Evidence map›Paper›PMID 29794137›Full record

ArticleThe Journal of biological chemistry2018

Restoration of hydroxyindole

Hua-Ling Chen, Chao-Yun Yuan, Huei-Hsuan Cheng, Tzu-Ching Chang, Shau-Ku Huang, Cheng-Chin Kuo, Kenneth K Wu

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cytoguardin: A Tryptophan Metabolite against Cancer Growth and Metastasis.International journal of molecular sciences · 2021
    Review
  7. Control of Mesenchymal Stromal Cell Senescence by Tryptophan Metabolites.International journal of molecular sciences · 2021
    Review
  8. Review
  9. Review
  10. Hydroxyindole-Heliyon · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Hua-Ling ChenFrom the Institute of Cellular and System Medicine and.
Chao-Yun YuanFrom the Institute of Cellular and System Medicine and.
Huei-Hsuan ChengMetabolomic Medicine Research Center, China Medical University Hospital, Taichung 40402, Taiwan.
Tzu-Ching ChangMetabolomic Medicine Research Center, China Medical University Hospital, Taichung 40402, Taiwan.
Shau-Ku HuangNational Institute of Environmental Health Sciences, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan.
Cheng-Chin KuoFrom the Institute of Cellular and System Medicine and kuocc@nhri.org.tw.
Kenneth K WuFrom the Institute of Cellular and System Medicine and kkgo@nhri.org.tw.ORCID 0000-0003-2306-6320
National Health Research Institutes · TWChina Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

5-Methoxytryptophan (5-MTP) is a tryptophan metabolite with recently discovered anti-inflammatory and tumor-suppressing activities. Its synthesis is catalyzed by a hydroxyindole

Indexed as

Acetylserotonin O-MethyltransferaseAnimalsApoptosisCell ProliferationHumansLung NeoplasmsMaleMiceMice, SCIDSerotoninTryptophanTumor Cells, CulturedXenograft Model Antitumor Assays5-methoxytryptophanAcetylserotonin O-MethyltransferaseSerotoninTryptophan5-methoxytryptophancancer biologycell metabolismenzymeHIOMThydroxyindole O-methyltransferasemelatoninmetastasistryptophan

Identifiers

PMID29794137
PMCPMC6052237
OpenAlexW2803849173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.